Skip to content
OpenCapital
Get started

INVO Fertility, Inc. IVF Q3 2025 earnings

Reported November 17, 2025 · Before market open

Revenue$1.8MMiss by $57.9K
EPS-$6.16Beat by $5.36
Revenue estimate$1.8M
EPS estimate-$11.52

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$2.4M
EPS estimate-$0.70

Versus estimates

Revenue

Q1 2026$2.0MBeat by $35.2KQ4 2025$1.9MIn line
Q3 2025$1.8MMiss by $57.9K
Q2 2025$1.9MMiss by $21.3KQ1 2025$1.6MBeat by $31.2KQ4 2024$1.7M

Diluted EPS

Q1 2026-$3.38Miss by $2.13Q4 2025-$3.38Miss by $0.63
Q3 2025-$6.16Beat by $5.36
Q2 2025-$63.60Miss by $49.20Q1 2025-$300.75Miss by $286.35Q4 2024-$11.71

Ask the moment INVO Fertility, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did INVO Fertility, Inc. report Q3 2025 earnings?
INVO Fertility, Inc. (IVF) reported Q3 2025 earnings on November 17, 2025 before market open.
What were INVO Fertility, Inc.'s Q3 2025 revenue and EPS?
INVO Fertility, Inc. reported revenue of $1.8M and eps of $-6.16 for Q3 2025.
Did INVO Fertility, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $1.8M by $57.9K. EPS beat the consensus estimate of $-11.52 by $5.36.
How did INVO Fertility, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.6% from $1.4M a year earlier and eps declined 22.2% from $-5.04.
Where can I find INVO Fertility, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023779) and the 10-Q periodic report (0001493152-25-023751) directly on SEC EDGAR. The filing index links above go to sec.gov.